Pulmonary embolism assessment of probability of subsequent VTE and risk scores

Jump to navigation Jump to search


Resident
Survival
Guide

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism assessment of probability of subsequent VTE and risk scores On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism assessment of probability of subsequent VTE and risk scores

CDC on Pulmonary embolism assessment of probability of subsequent VTE and risk scores

Pulmonary embolism assessment of probability of subsequent VTE and risk scores in the news

Blogs on Pulmonary embolism assessment of probability of subsequent VTE and risk scores

Directions to Hospitals Treating Pulmonary embolism assessment of probability of subsequent VTE and risk scores

Risk calculators and risk factors for Pulmonary embolism assessment of probability of subsequent VTE and risk scores

Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Venous thromboembolism (VTE) consists of deep vein thrombosis (DVT), pulmonary embolism (PE), or both. VTE is a disease associated with morbidity and mortality; therefore, VTE prophylaxis is indicated among specific categories of patients at elevated risk for VTE. Several scores have been developed for the assessment of risk of subsequent VTE such as the Padua prediction score and the IMPROVE score among hospitalized medically ill patients, and Roger's score and Caprini score among surgical patients.

Assessment of the Risk of Subsequent VTE in Medically Ill Patients

Padua Prediction Score for VTE

Calculation of the Padua Prediction Score

Shown below is a table depicting Padua predictive score for VTE among hospitalized medical patients.

Variable Score
Active cancer 3
Previous VTE 3
Decreased mobility 3
Thrombophilia 3
Previous trauma or surgery within that last month 2
Age≥ 70 1
Heart and/or respiratory failure 1
Ischemic stroke or acute myocardial infarction 1
Acute rheumatologic disorder and/or acute infection 1
Obesity 1
Hormonal therapy 1

Interpretation of the Padua Prediction Score

The interpretation of the score is as follows:

  • Score≥ 4: High risk for VTE
  • Score< 4: Low risk for VTE[1]

IMPROVE Predictive Score for VTE

Calculation of the IMPROVE Predictive Score

Variable Score[2]
Prior episode of VTE 3
Thrombophilia 3
Malignancy 1
Age more than 60 years 1

Interpretation of the IMPROVE Predictive Score

Score Predicted VTE risk through 3 months[2]
0 0.5%
1 1.0%
2 1.7%
3 3.1%
4 5.4%
5-8 11%

IMPROVE Associative Score for VTE

IMPROVE associative risk score assesses the risk of VTE among hospitalized medical patients. While the IMPROVE predictive score includes 4 independent risk factors for VTE which are present at admission, IMPROVE associative score includes 7 variables present either at admission or during hospitalization; however, the timing of the presence of some of the factors compared to the onset of VTE is not available.[2]

Calculation of the IMPROVE Associative Score

Variable Score[2]
Prior episode of VTE 3
Thrombophilia 2
Paralysis of the lower extremity during the hospitalization 2
Current malignancy 2
Immobilization for at least 7 days 1
ICU or CCU admission 1
Age more than 60 years 1

Interpretation of the IMPROVE Associative Score

Score Predicted VTE risk through 3 months[2]
0 0.4%
1 0.6%
2 1.0%
3 1.7%
4 2.9%
5-10 7.2%

Assessment of the Risk of Subsequent VTE in Surgery Patients

Rogers Score

Calculation of Rogers Score

Variable Score[3]
Pulmonary and hemic surgery 9
Thoracoabdominal aneurysm, embolectomy/thrombectomy, venous reconstruction, and endovascular repair surgery 7
Aneurysm surgery 4
Mouth or palate surgery 4
Stomach or intestines surgery 4
Integument surgery 3
Hernia surgery 2
American Society of Anesthesiologists (ASA) physical status classification 3, 4, or 5 2
ASA physical status classification 2 1
Female 1
Work relative value unit > 17 3
Work relative value unit 10−17 2
Disseminated malignancy 2
Chemotherapy for cancer in the last 30 days 2
Serum sodium > 145 mmol/L pre-op 2
Transfusion > 4 U packed red blood cells within 72 h pre-op 2
Dependency on ventilator 2
Wound class (clean/contaminated) 1
Hematocrit ≤ 38% pre-op 1
Bilirubin > 1.0 mg/dL pre-op 1
Dyspnea 1
Albumin ≤ 3.5 mg/dL 1
Emergency operation 1
ASA physical status classification 1 0
Work relative value unit < 10 0
Male 0

Interpretation of Rogers Score

The Rogers score is calculated by adding the scores of all factors present in the patient. The Rogers score is interpreted in the following way:[3]

  • Score 1-6: Low
  • Score 7-10: Moderate
  • Score > 10: High

Caprini Risk Assessment Model

Calculation of the Caprini Risk Score

Shown below is a table depicting the different scores for the factors included in the Caprini score.[4]

5 points 3 points 2 points 1 point
Stroke (in the previous month)
❑ Fracture of the hip, pelvis, or leg
❑ Elective arthroplasty
❑ Acute spinal cord injury (in the previous month)
Age≥ 75 years
❑ Prior episodes of VTE
❑ Positive family history for VTE
Prothrombin 20210 A
Factor V Leiden
Lupus anticoagulants
Anticardiolipin antibodies
❑ High homocysteine in the blood
Heparin induced thrombocytopenia
❑ Other congenital or acquired thrombophilia
❑ Age: 61-74 years
Arthroscopic surgery
Laparoscopy lasting more than 45 minutes
General surgery lasting more than 45 minutes
Cancer
Plaster cast
❑ Bed bound for more than 72 hours
❑ Central venous access
❑ Age 41-60 years
BMI > 25 Kg/m2
❑ Minor surgery
Edema in the lower extremities
Varicose veins
Pregnancy
Post-partum
Oral contraceptive
Hormonal therapy
❑ Unexplained or recurrent abortion
Sepsis (in the previous month)
❑ Serious lung disease such as pneumonia (in the previous month)
❑ Abnormal pulmonary function test
Acute myocardial infarction
Congestive heart failure (in the previous month)
❑ Bed rest
Inflammatory bowel disease

Interpretation of the Caprini Risk Score

The Caprini score is calculated by adding the scores of all factors present in the patient. The Caprini score is interpreted in the following way:[4][5]

  • Score 0-1: Low risk of VTE
  • Score 2: Moderate of VTE
  • Score 3-4: High risk of VTE
  • Score ≥ 5: Highest risk for VTE

References

  1. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M; et al. (2010). "A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score". J Thromb Haemost. 8 (11): 2450–7. doi:10.1111/j.1538-7836.2010.04044.x. PMID 20738765.
  2. 2.0 2.1 2.2 2.3 2.4 Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH; et al. (2011). "Predictive and associative models to identify hospitalized medical patients at risk for VTE". Chest. 140 (3): 706–14. doi:10.1378/chest.10-1944. PMID 21436241.
  3. 3.0 3.1 Rogers SO, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF (2007). "Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study". J Am Coll Surg. 204 (6): 1211–21. doi:10.1016/j.jamcollsurg.2007.02.072. PMID 17544079.
  4. 4.0 4.1 Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F (1991). "Clinical assessment of venous thromboembolic risk in surgical patients". Semin Thromb Hemost. 17 Suppl 3: 304–12. PMID 1754886.
  5. Caprini JA (2005). "Thrombosis risk assessment as a guide to quality patient care". Dis Mon. 51 (2–3): 70–8. doi:10.1016/j.disamonth.2005.02.003. PMID 15900257.

Template:WH Template:WS